Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.

Stathmin is a prognostic marker in many cancers, including endometrial cancer. Preclinical studies, predominantly in breast cancer, have suggested that stathmin may additionally be a predictive marker for response to paclitaxel. We first evaluated the response to paclitaxel in endometrial cancer cel...

Full description

Saved in:
Bibliographic Details
Main Authors: Henrica M J Werner, Jone Trovik, Mari K Halle, Elisabeth Wik, Lars A Akslen, Even Birkeland, Therese Bredholt, Ingvild L Tangen, Camilla Krakstad, Helga B Salvesen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0090141&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items